Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Alaska for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Alaska only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Alaska (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jacqueline Cox (NPI 1538153564)

Field	Value
Entity Type	Individual
Organization	Jacqueline Cox
Address	1640 Cowles St
City	Fairbanks
State	AK
ZIP	99701
Taxonomy	Hematology & Oncology Physician
NPI Enumerated	September 6, 2005

Payer Source	Total Paid
Medicare	$403.3K
Medicaid	$0

Key Findings

This provider’s Medicare billing is highly concentrated: Total Medicare revenue is $403.3K and the precomputed top 3 Medicare codes account for 88.2% of that total. J9271 (Injection, pembrolizumab, 1 mg) alone represents $304.1K (75.2% of this provider's total Medicare revenue) and is by far the single largest revenue driver on the profile.

Clinical service mix is consistent with an outpatient oncology/infusion practice: the dominant drug code J9271 points to routine administration of pembrolizumab, and chemotherapy administration codes such as 96413 (133 claims, $14.9K revenue), 96365 (43 claims, $2.3K revenue) and 96367 (88 claims, $2.3K revenue) appear in the top codes. High-level evaluation & management codes are also present — 99214 (252 claims, $29.2K revenue) and 99215 (138 claims, $23.3K revenue) — indicating the practice combines infusion delivery with complex office visits and care management.

This provider is effectively single-payer in the available data: there is no Medicaid billing on file, so Medicare accounts for the entirety of recorded public-payer activity. The absence of Medicaid billing suggests payer-mix analyses and contract negotiations should treat this profile as Medicare-dominated rather than multi-payer.

Competitive standing varies by service line. For the drug-focused revenue driver J9271 the provider ranks #1456 of 1841 providers nationally (21th percentile; typical, unremarkable volume for this code), which indicates a modest national presence for pembrolizumab administration despite the drug’s dominance in this provider’s revenue mix. By contrast, office visit utilization shows above-typical positioning: 99214 ranks #121530 of 479517 (75th percentile; typical, unremarkable volume for this code) and 99215 ranks #20026 of 145531 (86th percentile; typical, unremarkable volume for this code), suggesting stronger-than-average billing for higher-complexity visits relative to peers.

There are notable billing patterns that affect revenue-per-claim interpretation: J1453 (Injection, fosaprepitant, 1 mg) appears with 6.5K claims but $0 revenue, and J2469 (Injection, palonosetron hcl, 25 mcg) shows 350 claims and $350 revenue. These high-count, low-dollar entries materially reduce average paid-per-claim metrics and should be reviewed in claims-reconciliation or contract benchmarking exercises rather than being interpreted as high-revenue lines.

Provider tenure is long-standing: the NPI was enumerated 2005-09-06 (~21 years ago), which indicates an established enrollment history with Medicare and likely continuity of practice that can inform network participation and utilization trend analyses.

Overall revenue structure is drug-centric rather than procedure- or visit‑centric: J9271’s $304.1K dominates compared with chemotherapy administration code revenues (for example, 96413 $14.9K) and E/M revenues (for example, 99214 $29.2K). For payers and analysts, this means reimbursement variability or changes in drug pricing or utilization for pembrolizumab would have outsized impact on this provider’s Medicare revenue profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

27 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	7,600	$40	$304.1K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	250	$120	$29.2K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	140	$170	$23.3K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	130	$110	$14.9K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	60	$210	$12.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	50	$90	$4.5K
96417	In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy…	50	$50	$2.3K
96367	The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose…	90	$30	$2.3K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	40	$50	$2.3K
96375	Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the…	130	$10	$1.8K

Showing 1–10 of 27

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Alaska Distribution

Jacqueline Cox — 0 of 24 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Alaska

Full comparison — all codes billed, vs. state median

27 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	12	10	13,300	$40	$609.5K
96413	17	20	230	$110	$30.2K
99214	234	1,210	90	$100	$16.2K
99215	57	400	40	$150	$11K
99213	773	1,290	70	$70	$8.5K
99205	22	140	30	$190	$7.4K
96417	13	20	100	$60	$5.3K
96365	17	30	70	$50	$4.8K
96367	14	20	180	$20	$4.4K
96415	17	20	90	$30	$2.7K

Showing 1–10 of 27

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jacqueline Cox, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aimee Johnson	AK	Physician Assistant	$914.7K	$0
W William Cox	AK	Hematology & Oncology Physician	$472.4K	$0
Angela Emerson	AK	Physician Assistant	$403.8K	$0
Britni Browning	AK	Physician Assistant	$256.7K	$0
Dennis Beckworth	GU	Medical Oncology Physician	$6K	$0

Nearby Providers

Other providers in the same ZIP code as Jacqueline Cox, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tanana Chiefs Conference	AK	Multi-Specialty Clinic/Center	$0	$107.5M
Fairbanks Memorial Hospital, LLC	AK	General Acute Care Hospital	$0	$83.6M
Fairbanks Resource Agency Inc	AK	Community/Behavioral Health Agency	$0	$48M
Presbyterian Hospitality House	AK	Emotionally Disturbed Childrens' Residential Treatment Facility	$0	$34.9M
Fairbanks Native Association	AK	Substance Abuse Rehabilitation Facility	$0	$32.6M
Tanana Chiefs Confenerce	AK	Transportation Broker	$0	$24.1M
Tanana Chiefs Conference	AK	Community/Behavioral Health Agency	$0	$17M
Tanana Chiefs Conference	AK	Multi-Specialty Clinic/Center	$0	$16.3M
Restore LLC	AK	Substance Use Disorder Rehabilitation Clinic/Center	$0	$16.3M
Tanana Valley Clinic LLC	AK	Multi-Specialty Clinic/Center	$0	$15.2M

Jacqueline Cox — Billing Profile & Reimbursement Data

Sign up for Jacqueline Cox — Billing Profile & Reimbursement Data policy alerts

Jacqueline Cox — Billing Profile & Reimbursement Data

Sign up for Jacqueline Cox — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References